{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:23:41Z","timestamp":1782145421643,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T00:00:00Z","timestamp":1733616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T00:00:00Z","timestamp":1733616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009233","name":"College of Pharmacy, University of Minnesota","doi-asserted-by":"publisher","award":["SURRGE"],"award-info":[{"award-number":["SURRGE"]}],"id":[{"id":"10.13039\/100009233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003008","name":"Ministry of Higher Education, Egypt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010629","name":"Fulbright Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010629","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00204-024-03913-0","type":"journal-article","created":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T15:55:49Z","timestamp":1733673349000},"page":"729-744","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Canagliflozin differentially modulates carfilzomib-induced endoplasmic reticulum stress in multiple myeloma and endothelial cells"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9261-4234","authenticated-orcid":false,"given":"Mohamed S.","family":"Dabour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2887-9937","authenticated-orcid":false,"given":"Mina Y.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2963-4686","authenticated-orcid":false,"given":"Marianne K. O.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-4185","authenticated-orcid":false,"given":"Beshay N.","family":"Zordoky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,8]]},"reference":[{"issue":"2","key":"3913_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.drudis.2019.11.008","volume":"25","author":"F Alanazi","year":"2020","unstructured":"Alanazi F, Kwa FAA, Burchall G, Jackson DE (2020) New generation drugs for treatment of multiple myeloma. Drug Discov Today 25(2):367\u2013379. https:\/\/doi.org\/10.1016\/j.drudis.2019.11.008","journal-title":"Drug Discov Today"},{"issue":"7","key":"3913_CR2","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.3390\/ijms24076019","volume":"24","author":"H Bashiri","year":"2023","unstructured":"Bashiri H, Tabatabaeian H (2023) Autophagy: a potential therapeutic target to tackle drug resistance in multiple myeloma. Int J Mol Sci 24(7):6019. https:\/\/doi.org\/10.3390\/ijms24076019","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3913_CR3","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/s41419-021-04121-9","volume":"12","author":"M Bordi","year":"2021","unstructured":"Bordi M, De Cegli R, Testa B, Nixon RA, Ballabio A, Cecconi F (2021) A gene toolbox for monitoring autophagy transcription. Cell Death Dis 12(11):1044. https:\/\/doi.org\/10.1038\/s41419-021-04121-9","journal-title":"Cell Death Dis"},{"issue":"1","key":"3913_CR4","doi-asserted-by":"publisher","first-page":"13042","DOI":"10.1038\/s41598-024-63895-y","volume":"14","author":"J Chen","year":"2024","unstructured":"Chen J, Huang X, Zhang S, Zhu X (2024) ATF4 inhibits tumor development and mediates p-GCN2\/ASNS upregulation in colon cancer. Sci Rep 14(1):13042. https:\/\/doi.org\/10.1038\/s41598-024-63895-y","journal-title":"Sci Rep"},{"key":"3913_CR5","doi-asserted-by":"publisher","unstructured":"Costa-Mattioli M, Walter P (2020) The integrated stress response: from mechanism to disease. Science 368 (6489) https:\/\/doi.org\/10.1126\/science.aat5314","DOI":"10.1126\/science.aat5314"},{"key":"3913_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114907","volume":"164","author":"MS Dabour","year":"2023","unstructured":"Dabour MS, Abdelgawad IY, Grant MKO, El-Sawaf ES, Zordoky BN (2023) Canagliflozin mitigates carfilzomib-induced endothelial apoptosis via an AMPK-dependent pathway. Biomed Pharmacother 164:114907. https:\/\/doi.org\/10.1016\/j.biopha.2023.114907","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"3913_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jaccao.2024.01.007","volume":"6","author":"MS Dabour","year":"2024","unstructured":"Dabour MS, George MY, Daniel MR, Blaes AH, Zordoky BN (2024) The cardioprotective and anticancer effects of SGLT2 inhibitors: JACC: CardioOncology state-of-the-art review. JACC CardioOncol 6(2):159\u2013182. https:\/\/doi.org\/10.1016\/j.jaccao.2024.01.007","journal-title":"JACC CardioOncol"},{"issue":"5","key":"3913_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3724\/abbs.2024040","volume":"56","author":"Y Deng","year":"2024","unstructured":"Deng Y, Li Y, Yang M et al (2024) Carfilzomib activates ER stress and JNK\/p38 MAPK signaling to promote apoptosis in hepatocellular carcinoma cells. Acta Biochim Biophys Sin (Shanghai) 56(5):697\u2013708. https:\/\/doi.org\/10.3724\/abbs.2024040","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"1","key":"3913_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/icb.2014.85","volume":"93","author":"D Denton","year":"2015","unstructured":"Denton D, Xu T, Kumar S (2015) Autophagy as a pro-death pathway. Immunol Cell Biol 93(1):35\u201342. https:\/\/doi.org\/10.1038\/icb.2014.85","journal-title":"Immunol Cell Biol"},{"key":"3913_CR10","doi-asserted-by":"publisher","unstructured":"Efentakis P, Doerschmann H, Witzler C et al. (2020) Investigating the vascular toxicity outcomes of the irreversible proteasome inhibitor carfilzomib. Int J Mol Sci 21(15). https:\/\/doi.org\/10.3390\/ijms21155185","DOI":"10.3390\/ijms21155185"},{"issue":"6","key":"3913_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/antiox13060671","volume":"13","author":"MY George","year":"2024","unstructured":"George MY, Dabour MS, Rashad E, Zordoky BN (2024) Empagliflozin alleviates carfilzomib-induced cardiotoxicity in mice by modulating oxidative stress, inflammatory response, endoplasmic reticulum stress, and autophagy. Antioxidants 13(6):671. https:\/\/doi.org\/10.3390\/antiox13060671","journal-title":"Antioxidants"},{"issue":"5","key":"3913_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ncb2738","volume":"15","author":"J Han","year":"2013","unstructured":"Han J, Back SH, Hur J et al (2013) ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat Cell Biol 15(5):481\u2013490. https:\/\/doi.org\/10.1038\/ncb2738","journal-title":"Nat Cell Biol"},{"issue":"17","key":"3913_CR13","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79(17):1757\u20131780. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.011","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3913_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molcel.2017.06.017","volume":"69","author":"C Hetz","year":"2018","unstructured":"Hetz C, Papa FR (2018) The unfolded protein response and cell fate control. Mol Cell 69(2):169\u2013181. https:\/\/doi.org\/10.1016\/j.molcel.2017.06.017","journal-title":"Mol Cell"},{"issue":"10","key":"3913_CR15","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1182\/blood-2005-08-3434","volume":"107","author":"T Hideshima","year":"2006","unstructured":"Hideshima T, Catley L, Yasui H et al (2006) Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. Blood 107(10):4053\u20134062. https:\/\/doi.org\/10.1182\/blood-2005-08-3434","journal-title":"Blood"},{"issue":"2","key":"3913_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/leu.2013.301","volume":"28","author":"T Hideshima","year":"2014","unstructured":"Hideshima T, Mazitschek R, Santo L et al (2014) Induction of differential apoptotic pathways in multiple myeloma cells by class-selective histone deacetylase inhibitors. Leukemia 28(2):457\u2013460. https:\/\/doi.org\/10.1038\/leu.2013.301","journal-title":"Leukemia"},{"issue":"7","key":"3913_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","volume":"20","author":"MS Hipp","year":"2019","unstructured":"Hipp MS, Kasturi P, Hartl FU (2019) The proteostasis network and its decline in ageing. Nat Rev Mol Cell Biol 20(7):421\u2013435. https:\/\/doi.org\/10.1038\/s41580-019-0101-y","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"3913_CR18","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.jtha.2024.03.024","volume":"22","author":"A Hjazi","year":"2024","unstructured":"Hjazi A, Maroto CG, Rodriguez-Gutierrez ME et al (2024) The proteasome inhibitor carfilzomib exerts anti-inflammatory and antithrombotic effects on the endothelium. J Thromb Haemost 22(7):1867\u20131879. https:\/\/doi.org\/10.1016\/j.jtha.2024.03.024","journal-title":"J Thromb Haemost"},{"key":"3913_CR20","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.3389\/fimmu.2018.03083","volume":"9","author":"H Hu","year":"2018","unstructured":"Hu H, Tian M, Ding C, Yu S (2018) The C\/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection. Front Immunol 9:3083. https:\/\/doi.org\/10.3389\/fimmu.2018.03083","journal-title":"Front Immunol"},{"issue":"2","key":"3913_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/cancers12020265","volume":"12","author":"S Ito","year":"2020","unstructured":"Ito S (2020) Proteasome inhibitors for the treatment of multiple myeloma. Cancers (Basel) 12(2):265. https:\/\/doi.org\/10.3390\/cancers12020265","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3913_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2016.08.019","volume":"382","author":"V Jarauta","year":"2016","unstructured":"Jarauta V, Jaime P, Gonzalo O et al (2016) Inhibition of autophagy with chloroquine potentiates carfilzomib-induced apoptosis in myeloma cells in vitro and in vivo. Cancer Lett 382(1):1\u201310. https:\/\/doi.org\/10.1016\/j.canlet.2016.08.019","journal-title":"Cancer Lett"},{"issue":"12","key":"3913_CR23","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41419-021-04417-w","volume":"12","author":"HO Jin","year":"2021","unstructured":"Jin HO, Hong SE, Kim JY, Jang SK, Park IC (2021) Amino acid deprivation induces AKT activation by inducing GCN2\/ATF4\/REDD1 axis. Cell Death Dis 12(12):1127. https:\/\/doi.org\/10.1038\/s41419-021-04417-w","journal-title":"Cell Death Dis"},{"issue":"19","key":"3913_CR24","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1038\/onc.2009.66","volume":"28","author":"J Kang","year":"2009","unstructured":"Kang J, Perry J, Pandey V et al (2009) Artemin is oncogenic for human mammary carcinoma cells. Oncogene 28(19):2034\u20132045. https:\/\/doi.org\/10.1038\/onc.2009.66","journal-title":"Oncogene"},{"key":"3913_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174249","volume":"907","author":"P Kapadia","year":"2021","unstructured":"Kapadia P, Bikkina P, Landicho MA, Parekh S, Haas MJ, Mooradian AD (2021) Effect of anti-hyperglycemic drugs on endoplasmic reticulum (ER) stress in human coronary artery endothelial cells. Eur J Pharmacol 907:174249. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174249","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"3913_CR26","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/s41375-021-01141-4","volume":"35","author":"E Kastritis","year":"2021","unstructured":"Kastritis E, Laina A, Georgiopoulos G et al (2021) Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective study. Leukemia 35(5):1418\u20131427. https:\/\/doi.org\/10.1038\/s41375-021-01141-4","journal-title":"Leukemia"},{"issue":"9","key":"3913_CR27","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1038\/leu.2015.83","volume":"29","author":"S Kikuchi","year":"2015","unstructured":"Kikuchi S, Suzuki R, Ohguchi H et al (2015) Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma. Leukemia 29(9):1918\u20131927. https:\/\/doi.org\/10.1038\/leu.2015.83","journal-title":"Leukemia"},{"issue":"4","key":"3913_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.20452\/pamw.15896","volume":"131","author":"T Kubicki","year":"2021","unstructured":"Kubicki T, Gil L, Dytfeld D (2021) Endoplasmic reticulum stress and proteasome inhibitors in multiple myeloma: room for improvement. Pol Arch Intern Med 131(4):361\u2013368. https:\/\/doi.org\/10.20452\/pamw.15896","journal-title":"Pol Arch Intern Med"},{"issue":"9","key":"3913_CR29","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1182\/blood-2007-01-065888","volume":"110","author":"DJ Kuhn","year":"2007","unstructured":"Kuhn DJ, Chen Q, Voorhees PM et al (2007) Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma. Blood 110(9):3281\u20133290. https:\/\/doi.org\/10.1182\/blood-2007-01-065888","journal-title":"Blood"},{"issue":"18","key":"3913_CR30","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1158\/1078-0432.CCR-15-2522","volume":"22","author":"B Lamothe","year":"2016","unstructured":"Lamothe B, Wierda WG, Keating MJ, Gandhi V (2016) Carfilzomib triggers cell death in chronic lymphocytic leukemia by inducing proapoptotic and endoplasmic reticulum stress responses. Clin Cancer Res 22(18):4712\u20134726. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2522","journal-title":"Clin Cancer Res"},{"issue":"10","key":"3913_CR31","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/cdd.2011.27","volume":"18","author":"MA Laussmann","year":"2011","unstructured":"Laussmann MA, Passante E, D\u00fcssmann H et al (2011) Proteasome inhibition can induce an autophagy-dependent apical activation of caspase-8. Cell Death Differ 18(10):1584\u20131597. https:\/\/doi.org\/10.1038\/cdd.2011.27","journal-title":"Cell Death Differ"},{"key":"3913_CR32","doi-asserted-by":"publisher","unstructured":"Di Lernia G, Leone P, Solimando AG, et al. (2020) Bortezomib treatment modulates autophagy in multiple myeloma. J Clin Med 9(2). https:\/\/doi.org\/10.3390\/jcm9020552","DOI":"10.3390\/jcm9020552"},{"key":"3913_CR33","doi-asserted-by":"publisher","unstructured":"Li Y, Li S, Wu H (2022) Ubiquitination-proteasome system (UPS) and autophagy two main protein degradation machineries in response to cell stress. Cells 11(5). https:\/\/doi.org\/10.3390\/cells11050851","DOI":"10.3390\/cells11050851"},{"issue":"1","key":"3913_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s44319-023-00026-0","volume":"25","author":"K Liu","year":"2024","unstructured":"Liu K, Zhao C, Adajar RC, DeZwaan-McCabe D, Rutkowski DT (2024) A beneficial adaptive role for CHOP in driving cell fate selection during ER stress. EMBO Rep 25(1):228\u2013253. https:\/\/doi.org\/10.1038\/s44319-023-00026-0","journal-title":"EMBO Rep"},{"key":"3913_CR35","doi-asserted-by":"publisher","unstructured":"Oro\u0144 M, Grochowski M, Jaiswar A, et al. (2022) The molecular network of the proteasome machinery inhibition response is orchestrated by HSP70, revealing vulnerabilities in cancer cells. Cell Rep 40 (13). https:\/\/doi.org\/10.1016\/j.celrep.2022.111428","DOI":"10.1016\/j.celrep.2022.111428"},{"key":"3913_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2465","author":"MK Prasad","year":"2024","unstructured":"Prasad MK, Victor PS, Ganesh GV et al (2024) Sodium-glucose cotransporter-2 inhibitor suppresses endoplasmic reticulum stress and oxidative stress in diabetic nephropathy through Nrf2 signaling: a clinical and experimental study. J Clin Pharmacol. https:\/\/doi.org\/10.1002\/jcph.2465","journal-title":"J Clin Pharmacol"},{"issue":"7","key":"3913_CR37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41569-021-00511-w","volume":"18","author":"J Ren","year":"2021","unstructured":"Ren J, Bi Y, Sowers JR, Hetz C, Zhang Y (2021) Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases. Nat Rev Cardiol 18(7):499\u2013521. https:\/\/doi.org\/10.1038\/s41569-021-00511-w","journal-title":"Nat Rev Cardiol"},{"issue":"17","key":"3913_CR38","doi-asserted-by":"publisher","first-page":"14814","DOI":"10.18632\/oncotarget.4530","volume":"6","author":"I Riz","year":"2015","unstructured":"Riz I, Hawley TS, Hawley RG (2015) KLF4-SQSTM1\/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models. Oncotarget 6(17):14814\u201314831. https:\/\/doi.org\/10.18632\/oncotarget.4530","journal-title":"Oncotarget"},{"issue":"1","key":"3913_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.112","volume":"6","author":"A Rosenthal","year":"2016","unstructured":"Rosenthal A, Luthi J, Belohlavek M et al (2016) Carfilzomib and the cardiorenal system in myeloma: an endothelial effect? Blood Cancer J 6(1):e384. https:\/\/doi.org\/10.1038\/bcj.2015.112","journal-title":"Blood Cancer J"},{"issue":"1","key":"3913_CR40","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1186\/s12885-022-09775-y","volume":"22","author":"A Salimi","year":"2022","unstructured":"Salimi A, Schroeder KM, Schemionek-Reinders M et al (2022) Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK. BMC Cancer 22(1):735. https:\/\/doi.org\/10.1186\/s12885-022-09775-y","journal-title":"BMC Cancer"},{"issue":"1","key":"3913_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics. CA Cancer J Clin 74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3913_CR42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1124\/dmd.112.047662","volume":"41","author":"Z Wang","year":"2013","unstructured":"Wang Z, Yang J, Kirk C et al (2013) Clinical pharmacokinetics, metabolism, and drug-drug interaction of carfilzomib. Drug Metab Dispos 41(1):230\u2013237. https:\/\/doi.org\/10.1124\/dmd.112.047662","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"3913_CR43","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/cvr\/cvw047","volume":"110","author":"X Wang","year":"2016","unstructured":"Wang X, Ibrahim YF, Das D, Zungu-Edmondson M, Shults NV, Suzuki YJ (2016) Carfilzomib reverses pulmonary arterial hypertension. Cardiovasc Res 110(2):188\u2013199. https:\/\/doi.org\/10.1093\/cvr\/cvw047","journal-title":"Cardiovasc Res"},{"key":"3913_CR44","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbadis.2014.07.028","volume":"2","author":"CX Wang Wang","year":"1852","unstructured":"Wang Wang CX (1852) Wang X (2015) The interplay between autophagy and the ubiquitin\u2013proteasome system in cardiac proteotoxicity. Biochim Biophys Acta Mol Basis Dis 2:188\u2013194. https:\/\/doi.org\/10.1016\/j.bbadis.2014.07.028","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"3913_CR45","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.4519","volume":"4","author":"AJ Waxman","year":"2018","unstructured":"Waxman AJ, Clasen S, Hwang WT et al (2018) Carfilzomib-associated cardiovascular adverse events: a systematic review and meta-analysis. JAMA Oncol 4(3):e174519. https:\/\/doi.org\/10.1001\/jamaoncol.2017.4519","journal-title":"JAMA Oncol"},{"issue":"5","key":"3913_CR46","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1161\/CIRCRESAHA.123.323683","volume":"134","author":"G Yan","year":"2024","unstructured":"Yan G, Han Z, Kwon Y et al (2024) Integrated stress response potentiates ponatinib-induced cardiotoxicity. Circ Res 134(5):482\u2013501. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.323683","journal-title":"Circ Res"},{"issue":"5","key":"3913_CR47","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/bph.16229","volume":"181","author":"Y Ying","year":"2024","unstructured":"Ying Y, Ly S, Wl P et al (2024) Astragalus polysaccharide protects experimental colitis through an aryl hydrocarbon receptor-dependent autophagy mechanism. Br J Pharmacol 181(5):681\u2013697. https:\/\/doi.org\/10.1111\/bph.16229","journal-title":"Br J Pharmacol"},{"issue":"7","key":"3913_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219978","volume":"14","author":"SB Yoon","year":"2019","unstructured":"Yoon SB, Park YH, Choi SA et al (2019) Real-time PCR quantification of spliced X-box binding protein 1 (XBP1) using a universal primer method. PLoS ONE 14(7):e0219978. https:\/\/doi.org\/10.1371\/journal.pone.0219978","journal-title":"PLoS ONE"},{"key":"3913_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.735466","volume":"8","author":"Y Zhai","year":"2021","unstructured":"Zhai Y, Ye X, Hu F et al (2021) cardiovascular toxicity of carfilzomib: the real-world evidence based on the adverse event reporting system database of the FDA, the United States. Front Cardiovasc Med 8:735466. https:\/\/doi.org\/10.3389\/fcvm.2021.735466","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"3913_CR50","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s41419-022-05390-8","volume":"13","author":"C Zhao","year":"2022","unstructured":"Zhao C, Li X, Sun G et al (2022) CircFOXO3 protects against osteoarthritis by targeting its parental gene FOXO3 and activating PI3K\/AKT-mediated autophagy. Cell Death Dis 13(11):932. https:\/\/doi.org\/10.1038\/s41419-022-05390-8","journal-title":"Cell Death Dis"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03913-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-024-03913-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03913-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T06:35:15Z","timestamp":1738132515000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-024-03913-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,8]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3913"],"URL":"https:\/\/doi.org\/10.1007\/s00204-024-03913-0","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,8]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}